PHARMA 2100 ApS: Financial statements 2013
CVR: 26382785
Source: annual report 2013, Danish Business Authority
01/07/2012 – 30/06/2013
PHARMA 2100 ApS (CVR 26382785) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -250 and a net result of DKK -25,250 compared with DKK -50,000 the year before. Equity in the 2013 report amounted to DKK 57,340. The solvency ratio was 69.4%.
- Revenue
- DKK 0
- Gross Profit
- DKK -250
- Profit/Loss
- DKK -25,250
- Equity
- DKK 57,340
- Total Assets
- DKK 82,590
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
PHARMA 2100 ApS has published its annual report for 2012. Revenue came to DKK 0, and the net result was DKK -50,000.
About PHARMA 2100 ApS
PHARMA 2100 ApS was a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002. The company has been dissolved on 23 October 2018. The company was registered under the industry Industriel design og produktdesign. The company was previously named SCSK 6014 ApS. The company has 1 employee (2009). In 2017, the company reported a gross profit of DKK -20,455 and a net result of DKK -20,455 compared with DKK 0 the year before. Equity in the 2017 report amounted to DKK 29,371.